← Open Payments lookup

CLARA ARREY: Open Payments

NPI 1669906681 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$981 in 37 payments from 6 companies in 2025. Trend: 2023 $862 · 2024 $577 · 2025 $981

Food & beverage: $981
CompanyPaymentsAmount
Alkermes, Inc.18$528
Teva Pharmaceuticals USA, Inc.10$265
Otsuka America Pharmaceutical, Inc.5$103
E.R. Squibb & Sons, L.L.C.2$42
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$29
Luye Pharma (USA) Ltd.1$14

Products named: ARISTADA, AUSTEDO XR, LYBALVI, ABILIFY MAINTENA, UZEDY, COBENFY, CAPLYTA, ERZOFRI EXTENDED-RELEASE.

Industry payments across TX — which companies pay providers there.